Biofil Chemicals & Pharmaceuticals Management Change
Biofil Chemicals & Pharmaceuticals shareholders approved the continuation of Mr. Ashok Kumar Ramawat as a Non-Executive Independent Director, despite him exceeding 75 years of age.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Biofil Chemicals & Pharmaceuticals shareholders approved the continuation of Mr. Ashok Kumar Ramawat as a Non-Executive Independent Director, despite him exceeding 75 years of age.
Biofil Chemicals and Pharmaceuticals Limited held its 41st Annual General Meeting on 23rd September 2026. Members transacted routine business, including adoption of financial statements and director re-appointments.
Biofil Chemicals & Pharmaceuticals Ltd reported revenue from operations of ₹12.4 Cr (+93.8% YoY) and net profit of ₹0.1 Cr (-95.8% YoY) for Q1 FY27.
Biofil Chemicals & Pharmaceuticals Ltd reported revenue from operations of ₹7.6 Cr (-9.5% YoY) and net profit of ₹0.2 Cr (+0.0% YoY) for Q4 FY26.